masked dexcom g6 pro cgm sensors (Dexcom Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Dexcom Inc masked dexcom g6 pro cgm sensors
Masked Dexcom G6 Pro Cgm Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g6+pro+cgm+sensor/blood+glucose+monitor/10__1097_slash_grf__0000000000001010-27-6-7
Average 86 stars, based on 1 article reviews

masked dexcom g6 pro cgm sensors - by Bioz Stars, 2026-09

86/100 stars

Images

Biomarker Discovery:

Article Title: Defining continuous glucose monitor time in range in a large community-based cohort without diabetes.
Article Snippet: .. Our study included grandchildren of the original Framingham Heart Study (FHS) cohort who were enrolled in 26 the Third Generation (n=4095), New Offspring Spouses (n=103), or Omni 2 (n=410) cohorts in 2002. (8) Our 27 study included participants from these cohorts who attended the fourth examination from September 2022 to 28 AC CE PT ED M AN US CR IP T D ow nloaded from https://academ ic.oup.com /jcem /advance-article/doi/10.1210/clinem /dgae626/7754867 by guest on 12 Septem ber 2024 December 31, 2023 (n=1699) and wore a Dexcom G6 Pro CGM sensor for at least 7 full days on their upper 1 arm or abdomen, with an available HbA1c and fasting glucose measurement (n=1175, Supplemental Figure 2 1). (9) Diabetes was defined using self-report (current diagnosis or history of diabetes), HbA1c ≥6.5% (≥48 3 mmol/mol), venous fasting glucose ≥126mg/dL, or taking glucose-lowering medications at the time of their 4 study visit (n=152), prediabetes was defined if participants had either HbA1c 5.7-6.4% (39-47mmol/mol) and/or 5 venous fasting glucose 100-125 mg/dL (n=463), and remaining participants did not meet criteria for 6 prediabetes or diabetes, and will be described as having “normoglycemia” for this report (n=560). ..

Medications:

other:

Article Title: Effect of High-Intensity Interval Training on Fasting Hyperglycemia in People With Isolated Impaired Fasting Glucose: A Proof-of-Concept Study
Article Snippet: On the first day of the intervention, each participant will be fitted with a Dexcom G6 Pro CGM sensor beneath the skin by trained study staff.

Article Title: Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes
Article Snippet: When participants came to the FHS Research Center for their study visit, a research technician applied a single Dexcom G6 Pro CGM sensor (Dexcom Inc) to their upper arm or abdomen, in the blinded mode.

Selection:

Article Title: Effects of the COVID-19 booster vaccine on glycemia and insulin resistance in people with type 1 diabetes: A prospective pilot study.
Article Snippet: Aims: Inflammation can trigger hyperglycemia in people with type 1 diabetes (T1D).. Vaccines purposefully intend to cause an acute immunogenic response, and booster vaccines may cause even more potent immunologic responses.. However, the effects of vaccines on glycemic control and insulin requirements in the days immediately post-vaccination remains poorly understood.

Review